Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine
Don D SinS F Paul Man

Abstract

Systemic inflammation is present in chronic obstructive pulmonary disease (COPD), which has been linked to cardiovascular morbidity and mortality. We determined the effects of oral and inhaled corticosteroids on serum markers of inflammation in patients with stable COPD. We recruited 41 patients with mild to moderate COPD. After 4 weeks during which inhaled corticosteroids were discontinued, patients were assigned to fluticasone (500 mcg twice a day), oral prednisone (30 mg/day), or placebo over 2 weeks, followed by 8 weeks of fluticasone at 500 mcg twice a day and another 8 weeks at 1,000 mcg twice a day. Withdrawal of inhaled corticosteroids increased baseline C-reactive protein (CRP) levels by 71% (95% confidence interval [CI], 16-152%). Two weeks with inhaled fluticasone reduced CRP levels by 50% (95% CI, 9-73%); prednisone reduced it by 63% (95% CI, 29-81%). No significant changes were observed with the placebo. An additional 8 weeks of fluticasone were associated with CRP levels that were lower than those at baseline (a 29% reduction; 95% CI, 7-46%). Inhaled and oral corticosteroids are effective in reducing serum CRP levels in patients with COPD and suggest their potential use for improving cardiovascular outcomes in COPD.

Associated Clinical Trials

References

Apr 15, 1991·American Journal of Epidemiology·A E CamilliM D Lebowitz
Jan 1, 1990·Annual Review of Immunology·J Van Snick
May 29, 1998·American Journal of Respiratory and Critical Care Medicine·T A SeemungalJ A Wedzicha
Jan 14, 1999·The New England Journal of Medicine·R Ross
Nov 11, 1999·American Journal of Respiratory and Critical Care Medicine·G BalzanoG Melillo
Nov 11, 1999·American Journal of Respiratory and Critical Care Medicine·S V CulpittP J Barnes
Jan 3, 2001·The New England Journal of Medicine·UNKNOWN Lung Health Study Research GroupMelissa Skeans
Jun 30, 2001·The New England Journal of Medicine·P M RidkerUNKNOWN Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators
Jun 19, 2002·American Journal of Respiratory and Critical Care Medicine·Keith L HattotuwaNeil C Barnes
Aug 3, 2002·American Journal of Respiratory and Critical Care Medicine·Nicholas R AnthonisenUNKNOWN Lung Health Study Research Group
Oct 16, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Edmund A BermudezPaul M Ridker
Dec 12, 2002·Journal of the American College of Cardiology·Francesco VersaciUNKNOWN Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation Study
Jun 19, 2003·The Journal of Clinical Investigation·Mark B Pepys, Gideon M Hirschfield
Jul 29, 2003·The European Respiratory Journal·I S PatelJ A Wedzicha
Oct 22, 2003·Circulation·Paul E SzmitkoSubodh Verma
Oct 30, 2003·The European Respiratory Journal·P J BarnesR A Pauwels
Nov 6, 2003·JAMA : the Journal of the American Medical Association·Don D SinNick R Anthonisen

❮ Previous
Next ❯

Citations

Mar 17, 2006·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·C M GordonA A Colin
Jan 21, 2011·Internal and Emergency Medicine·Massimo MiniatiValter Lubrano
Aug 25, 2005·Archivos de bronconeumología·J L Izquierdo Alonso, R Arroyo-Espliguero
Dec 20, 2007·Journal of Hypertension·Frank de VriesTjeerd van Staa
Jun 18, 2009·Current Opinion in Pulmonary Medicine·Andreea L Antonescu-Turcu, Rade Tomic
Nov 25, 2011·Current Opinion in Pulmonary Medicine·Pierre Ernst, Samy Suissa
Oct 24, 2008·Respirology : Official Journal of the Asian Pacific Society of Respirology·Agustín Ruiz-GonzálezJosé M Porcel
Sep 15, 2006·Journal of General Internal Medicine·Shelley R SalpeterEdwin E Salpeter
Jun 2, 2006·Thorax·R Rodríguez-Roisin
Jan 25, 2006·Respiration; International Review of Thoracic Diseases·H A C van HelvoortP N R Dekhuijzen
Dec 5, 2006·Respiration; International Review of Thoracic Diseases·Erdogan KunterZafer Kartaloğlu
Nov 29, 2007·Respiration; International Review of Thoracic Diseases·Stephan F van Eeden, Don D Sin
May 10, 2005·American Journal of Respiratory and Critical Care Medicine·Brian J Lipworth, Daniel Menzies
May 10, 2005·American Journal of Respiratory and Critical Care Medicine·J Christian Virchow
Mar 15, 2005·American Journal of Respiratory and Critical Care Medicine·Hiroyasu YasudaHidetada Sasaki
Jun 17, 2006·American Journal of Respiratory and Critical Care Medicine·Doron AronsonWalter Markiewicz
Oct 21, 2006·American Journal of Respiratory and Critical Care Medicine·Peter KardosClaus Vogelmeier
Oct 21, 2006·American Journal of Respiratory and Critical Care Medicine·Morten DahlBørge G Nordestgaard
Dec 23, 2006·American Journal of Respiratory and Critical Care Medicine·Tanyalak ParimonDavid H Au
Jan 20, 2007·American Journal of Respiratory and Critical Care Medicine·Gavin C Donaldson
Mar 4, 2008·American Journal of Respiratory and Critical Care Medicine·Don D SinUNKNOWN ABC (Advair, Biomarkers in COPD) Investigators
May 20, 2008·American Journal of Respiratory and Critical Care Medicine·Morten Dahl
Apr 4, 2009·American Journal of Respiratory and Critical Care Medicine·Valérie DufresneMarc Estenne
Dec 20, 2008·American Journal of Respiratory and Critical Care Medicine·Yannick M T A van DurmeBruno H C Stricker
Jun 5, 2010·American Journal of Respiratory and Critical Care Medicine·MeiLan K HanFernando J Martinez
Apr 23, 2011·American Journal of Respiratory and Critical Care Medicine·Dennis ChenEric M Mortensen
Sep 28, 2004·American Journal of Respiratory and Critical Care Medicine·Peter Calverley
Dec 14, 2004·American Journal of Respiratory and Critical Care Medicine·Sanjay Sethi
Mar 26, 2005·American Journal of Respiratory and Critical Care Medicine·Leonardo FabbriEdward Abraham
Jun 9, 2006·American Journal of Respiratory and Critical Care Medicine·Bartolome R Celli
May 9, 2006·American Journal of Respiratory and Critical Care Medicine·Leonardo M FabbriKlaus F Rabe
Dec 21, 2010·American Journal of Respiratory Cell and Molecular Biology·Koichi SudaDon D Sin
Mar 1, 2010·Therapeutic Advances in Chronic Disease·Nicola J Sinden, Robert A Stockley
Apr 3, 2012·BMC Medical Research Methodology·José L López-CamposAna Montes-Worboys
Jul 21, 2009·BMC Pulmonary Medicine·Pål H BrekkeVidar Søyseth
Sep 17, 2013·PloS One·Jordi AlmirallUNKNOWN Community-Acquired Pneumonia in Catalan Countries (PACAP)

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

American Thoracic Association Journals

Discover the latest respiratory research published by the journals from the American Thoracic Society.